|
gptkbp:instanceOf
|
gptkb:drug
gptkb:proton_pump_inhibitor
|
|
gptkbp:approvedBy
|
1997
|
|
gptkbp:ATCCode
|
A02BC04
|
|
gptkbp:bioavailability
|
52%
|
|
gptkbp:brand
|
gptkb:Acidil
Acidil Plus
Acidil-20
Acidil-DS
Acidil-DSR
Acidil-DSR Plus
Acidil-DSR-20
Acidil-DSR-DS
Acidil-DSR-DSR
Acidil-DSR-DSR Plus
Acidil-DSR-DSR-20
Acidil-DSR-DSR-DS
Acidil-DSR-DSR-DSR
Acidil-DSR-DSR-IT
Acidil-DSR-DSR-ITR
Acidil-DSR-DSR-L
Acidil-DSR-IT
Acidil-DSR-ITR
Acidil-DSR-L
Acidil-IT
Acidil-ITR
Acidil-L
Acidil-R
Pariet
|
|
gptkbp:CASNumber
|
117976-89-3
|
|
gptkbp:chemicalFormula
|
C18H21N3O3S
|
|
gptkbp:discoveredBy
|
gptkb:Eisai
|
|
gptkbp:eliminationHalfLife
|
1-2 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
inhibits H+/K+ ATPase in gastric parietal cells
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
359.44 g/mol
|
|
gptkbp:pregnancyCategory
|
C (US)
B3 (Australia)
|
|
gptkbp:proteinBinding
|
96.3%
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
diarrhea
abdominal pain
headache
rash
|
|
gptkbp:usedFor
|
gptkb:Zollinger-Ellison_syndrome
gptkb:gastroesophageal_reflux_disease
gptkb:peptic_ulcer_disease
|
|
gptkbp:bfsParent
|
gptkb:proton_pump_inhibitors
gptkb:Nexium
gptkb:CYP3A4
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
rabeprazole
|